Skip to Main Content
Legislation Search

H.R. 6220: Maddie’s Infant Recovery And Children’s Legislative Emergency Act of 2025

This bill, known as the Maddie’s Infant Recovery And Children’s Legislative Emergency Act of 2025, aims to address the issue of neonatal abstinence syndrome (NAS), which affects newborns exposed to harmful substances before birth. The key components of the bill are outlined below:

Conduct a Study

The Secretary of Health and Human Services is directed to conduct a comprehensive study focusing on:

  • The prevalence of neonatal abstinence syndrome (NAS).
  • Health outcomes for both infants and mothers related to pediatric transitional care facilities.

Identify Barriers and Services

While conducting the study, the Secretary is required to:

  • Identify the challenges in gathering accurate data on NAS among individuals covered under State Medicaid plans.
  • Evaluate the range of services and supports available to beneficiaries diagnosed with NAS under these State plans.

Report to Congress

Within three years of the bill’s enactment, the Secretary must submit a report to Congress that includes:

  • Findings from the study.
  • Recommendations for addressing issues related to NAS, if applicable.

Upon submitting the report to Congress, it must also be made publicly available on a website.

Definitions

The bill defines key terms, including:

  • Pediatric transitional care facility: A residential center catering to infants with NAS that offers inpatient or outpatient treatment.
  • State: This term encompasses all U.S. states, the District of Columbia, and U.S. territories.

Additional Purpose

The legislation is a response to growing concerns about the health impacts of substance exposure during pregnancy and aims to improve the care and recovery options for affected infants and their families.

Relevant Companies

None found

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

4 bill sponsors

Actions

2 actions

Date Action
Nov. 20, 2025 Introduced in House
Nov. 20, 2025 Referred to the House Committee on Energy and Commerce.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

No relevant congressional stock trades found.